PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Password Reminder
Not Registered? Click Here

Register

Register
It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: Manager factsheet

Gareth Powell
Polar Capital, Polar Capital Partners Ltd
pdfIcon Manager factsheet pdf    rss feed RSS Feed
Manager profile
Gareth joined Polar Capital in 2007 to set up the healthcare team. He has over 22 years’ investment experience in the healthcare sector, with 14 years as a Portfolio Manager. Prior to Polar Capital, Gareth worked at Framlington, where he began his career in investment management in 1999. Soon afterwards, he joined the Healthcare Team in 2001 and helped launch the Framlington Biotech Fund, which he managed from 2004 until his departure. Gareth studied biochemistry at Oxford, during which time he worked at Yamanouchi, a leading Japanese pharmaceutical company (later to become Astellas), as well as various academic laboratories including the Sir William Dunn School of Pathology, the Wolfson Institute for Biomedical Research and Oxford Business School. He is a CFA charterholder.
Total return for Gareth Powell
Manager career performance
Discrete calendar year performance : Gareth Powell

Manager career performance
Discrete performance
  0-12m 12-24m 24-36m 36-48m 48-60m 60-72m 72-84m 84-96m 96-108m 108-120m
Gareth Powell 19.3 5.3 11.8 28.8 -8.8 27.0 -4.1 29.2 -10.5 32.3
Peer Group Composite 7.5 -1.6 -6.5 30.5 0.4 18.5 -3.2 30.2 -15.4 48.5
Over / Under 11.8 6.9 18.3 -1.7 -9.2 8.5 -0.9 -1.0 4.9 -16.2
Performance vs peer group composite: Gareth Powell
How a manager matches up against their peers gives you some idea of how talented they are. Very few managers perform equally well in rising and falling markets, so knowing which type of market a manager is capable of performing well within is also important.
 
Overall markets
Up
Outperformed peer group composite
5 years
out of a possible 10
 
Overall markets
Up
Underperformed peer group composite
5 years
out of a possible 10
 
Rising markets
UpDown
Outperformed peer group composite
2 years
out of a possible 6
 
Falling markets
UpDown
Outperformed peer group composite
3 years
out of a possible 4
Funds currently managed
Fund Sole/Co-managed Sector Periods
Polar Capital Healthcare Opportunities Lead manager IA Healthcare since Nov 30 2007 to present
Polar Capital Global Healthcare Trust PLC Co-managed IT Biotechnology & Healthcare since Jun 15 2010 to present
Funds managed previously
Fund Periods
Polar Capital Healthcare Blue Chip since Sep 11 2014 to Jul 31 2019
AXA Framlington Biotech since Jan 01 2004 to Aug 31 2007
Polar Capital Biotechnology since Oct 31 2013 to Mar 31 2014
News & Research: Related articles sector Sector fund Fund group Group manager Manager
Group Bubble trouble, the case for infrastructure and Polar Capital on healthcare: Thoughts from Fundswire this week By Diana Llewellyn  12-Apr-2024
Fund The most consistent technology, healthcare and financial funds of the decade By Matteo Anelli  12-Apr-2024
Group Canaccord’s four unloved areas full of opportunities By Jean-Baptiste Andrieux  08-Apr-2024
Sector Funds for junior ISAs to profit from long-term trends By Emma Wallis  04-Apr-2024
Group The best and worst funds of Q1 2024 By Gary Jackson  04-Apr-2024
Group Revealed: The nominees for the Alpha Manager of the Year Awards 2024 By Emma Wallis  28-Mar-2024
Group AJ Bell’s six ISA funds for investors of all risk tolerances By Jonathan Jones  27-Mar-2024
Group Too many managers are worried about career risk, says IBOSS’ Metcalfe By Jonathan Jones  27-Mar-2024
Group The fund managers investing in each other By Emma Wallis  26-Mar-2024
Group This couple left £60,000 in cash for three years: Here’s how they should invest it By Emma Wallis  26-Mar-2024
Sector Tech vs biotech: Is it time to look beyond the Magnificent Seven? By Jo Groves  21-Mar-2024
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

LATEST :

Five reasons to keep hold of your defensive funds

13:00 | Monday, January 20, 2014

Close

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close

© Trustnet Limited 2024. All Rights Reserved.
Please read our Terms of Use / Disclaimer and Privacy and Cookie Policy.
Data supplied in conjunction with Refinitiv and London Stock Exchange Plc